search
Back to results

Adaptive Servo-Ventilation in "Real Life" Conditions : the OTRLASV Study (OTRLASV)

Primary Purpose

Chronic Heart Failure and, Complex Sleep Apnea Syndrome, Obstructive Sleep Apnea Syndrome and

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Adaptive Servo-Ventilation
Sponsored by
University Hospital, Montpellier
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Chronic Heart Failure and focused on measuring Adaptive Servo-Ventilation, Chronic Heart Failure, Central Sleep Apnea Syndrome, Central and Obstructive Sleep Apnea Syndrome, Complex Sleep Apnea Syndrome, Hunter-Cheyne-Stokes Breathing, Periodic Breathing

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Written informed consent
  • Age more than 18 years (inclusive)
  • Patient treated with ASV for at least one year,and eligible for care and for the reimbursement by the French Social Security rules.
  • Patient presenting at the annual control consultation for the continuation of the ASV treatment according to the French Social Security rules.

Exclusion Criteria:

  • Pregnancy, intention of being pregnant, breastfeeding.
  • Inability to understand the nature and aims of the study or to communicate with the investigator
  • Simultaneous participation in another trial with an exclusion clause to participate to an other trial.
  • No affiliation to the French social security
  • Loss of personal capacity resulting in state protection
  • Deprivation of liberty by judicial or administrative decision

Sites / Locations

  • Polyclinic Saint-Privat
  • CHU Dijon
  • Hôpital Nord
  • Arnaud de Villeneuve University Hospital
  • Hôpital Pitié Salpetrière

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

ASV Arm

Arm Description

The measures are performed during the annual consultation required by the French Social Security for the renewal of the reimbursement of the ASV care.

Outcomes

Primary Outcome Measures

Residual Apnea Hypopnea Index (AHI) evaluated by the ASV device and associated pressure settings
Relationship between the residual AHI and the associated pressure settings, in function of the phenotype of the patients (presence or absence of cardiopathy, presence or absence of altered left ventricular ejection fraction (≤45% or > 45%)

Secondary Outcome Measures

Sleep Disorder Breathing involved in the initial prescription of ASV
The data are obtained after questioning the patient (Epworth, Pichot and satisfaction scales) or after analysis of the six latest months data of the device or after analysis of the polygraphy/oximetry (if necessary and prescribed by the doctor in order to monitoring the patient for the renewal consultation of the ASV care and reimbursement by the French Social Security).
ASV compliance (number of hour per day, number of day with ≥3 hours in the past 6 months)
The data are obtained after questioning the patient (Epworth, Pichot and satisfaction scales) or after analysis of the six latest months data of the device or after analysis of the polygraphy/oximetry (if necessary and prescribed by the doctor in order to monitoring the patient for the renewal consultation of the ASV care and reimbursement by the French Social Security).
Type of device used nad history of device used (CPAP used before ASV ?)
The data are obtained after questioning the patient (Epworth, Pichot and satisfaction scales) or after analysis of the six latest months data of the device or after analysis of the polygraphy/oximetry (if necessary and prescribed by the doctor in order to monitoring the patient for the renewal consultation of the ASV care and reimbursement by the French Social Security)
Used or not of an auto-EPAP
The data are obtained after questioning the patient (Epworth, Pichot and satisfaction scales) or after analysis of the six latest months data of the device or after analysis of the polygraphy/oximetry (if necessary and prescribed by the doctor in order to monitoring the patient for the renewal consultation of the ASV care and reimbursement by the French Social Security).
Settings of the device (Inspiratory and Expiratory pressures, duration of pressurization, backup frequency)
The data are obtained after questioning the patient (Epworth, Pichot and satisfaction scales) or after analysis of the six latest months data of the device or after analysis of the polygraphy/oximetry (if necessary and prescribed by the doctor in order to monitoring the patient for the renewal consultation of the ASV care and reimbursement by the French Social Security).
Type of mask used and historical use of mask
The data are obtained after questioning the patient (Epworth, Pichot and satisfaction scales) or after analysis of the six latest months data of the device or after analysis of the polygraphy/oximetry (if necessary and prescribed by the doctor in order to monitoring the patient for the renewal consultation of the ASV care and reimbursement by the French Social Security).
Changes in AHI as compared to baseline
The data are obtained after questioning the patient (Epworth, Pichot and satisfaction scales) or after analysis of the six latest months data of the device or after analysis of the polygraphy/oximetry (if necessary and prescribed by the doctor in order to monitoring the patient for the renewal consultation of the ASV care and reimbursement by the French Social Security).
Changes in Daytime Sleepiness by measuring Epworth scale as compared to baseline if available
The data are obtained after questioning the patient (Epworth, Pichot and satisfaction scales) or after analysis of the six latest months data of the device or after analysis of the polygraphy/oximetry (if necessary and prescribed by the doctor in order to monitoring the patient for the renewal consultation of the ASV care and reimbursement by the French Social Security).
Changes in Asthenia by measuring Pichot scale as compared to baseline if available
The data are obtained after questioning the patient (Epworth, Pichot and satisfaction scales) or after analysis of the six latest months data of the device or after analysis of the polygraphy/oximetry (if necessary and prescribed by the doctor in order to monitoring the patient for the renewal consultation of the ASV care and reimbursement by the French Social Security).
Number of hospitalization during the last year and etiology of the hospitalization
The data are obtained after questioning the patient (Epworth, Pichot and satisfaction scales) or after analysis of the six latest months data of the device or after analysis of the polygraphy/oximetry (if necessary and prescribed by the doctor in order to monitoring the patient for the renewal consultation of the ASV care and reimbursement by the French Social Security).
Presence of a cardiomyopathy
The data are obtained after questioning the patient (Epworth, Pichot and satisfaction scales) or after analysis of the six latest months data of the device or after analysis of the polygraphy/oximetry (if necessary and prescribed by the doctor in order to monitoring the patient for the renewal consultation of the ASV care and reimbursement by the French Social Security).
Treatment of the cardiomyopathy (medication consumption and use of cardiac implant will be reported)
The data are obtained after questioning the patient (Epworth, Pichot and satisfaction scales) or after analysis of the six latest months data of the device or after analysis of the polygraphy/oximetry (if necessary and prescribed by the doctor in order to monitoring the patient for the renewal consultation of the ASV care and reimbursement by the French Social Security).
Number of patients not showing up for the annual consultation
The data are obtained after questioning the patient (Epworth, Pichot and satisfaction scales) or after analysis of the six latest months data of the device or after analysis of the polygraphy/oximetry (if necessary and prescribed by the doctor in order to monitoring the patient for the renewal consultation of the ASV care and reimbursement by the French Social Security).

Full Information

First Posted
April 1, 2015
Last Updated
September 24, 2020
Sponsor
University Hospital, Montpellier
search

1. Study Identification

Unique Protocol Identification Number
NCT02429986
Brief Title
Adaptive Servo-Ventilation in "Real Life" Conditions : the OTRLASV Study
Acronym
OTRLASV
Official Title
Observational and Transversal Study of Patients Treated in "Real Life"Conditions With Adaptive Servo-Ventilation
Study Type
Interventional

2. Study Status

Record Verification Date
September 2020
Overall Recruitment Status
Completed
Study Start Date
March 13, 2015 (Actual)
Primary Completion Date
January 17, 2017 (Actual)
Study Completion Date
January 17, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Montpellier

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Adaptive Servo-Ventilation (ASV) treatment is routinely prescribed in France. In order to be reimbursed according to the French Social Security rules, the patient treated with an ASV needs to be examined each year. In this observational transversal single-visit study, the investigators aim to describe the clinical characteristics of patients treated with ASV and the associated device settings.
Detailed Description
The purpose of this study is to evaluate in "real life conditions" the use of Adaptative Servo-Ventilation (ASV) treatment. ASV treatment is routinely prescribed in France in patients with various sleep disorders breathing (Chronic Heart Failure (CHF) and Central Sleep Apnea Syndrome (CSAS), CHF and central and obstructive sleep apnea (COSA), Obstructive Sleep Apnea Syndrome (OSAS) and complex sleep apnea syndrome (compSAS), idiopathic or drug induced periodic breathing. In order to be reimbursed according to the French Social Security rules, the patient treated with an ASV needs to be examined each year. In this observational transversal single-visit study, the aim is to describe the clinical characteristics of patients treated with ASV and the associated device settings. The aim is to evaluate the safety and efficacy issues in real life conditions of the ASV prescription.Depending of the data, data are obtained after analysis of the six latest months data of the ASV device, after questioning the patient, after analysis of the polygraphy/oximetry (if prescribed by the doctor for the renewal consultation of the ASV care and reimbursement by the French Social Security). All the data are obtained during the annual consultation required by the French Social Security.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Heart Failure and, Complex Sleep Apnea Syndrome, Obstructive Sleep Apnea Syndrome and, Idiopathic Central Sleep Apnea Syndrome, Idiopathic Induced Periodic Breathing, Central Sleep Apnea Syndrome
Keywords
Adaptive Servo-Ventilation, Chronic Heart Failure, Central Sleep Apnea Syndrome, Central and Obstructive Sleep Apnea Syndrome, Complex Sleep Apnea Syndrome, Hunter-Cheyne-Stokes Breathing, Periodic Breathing

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
214 (Actual)

8. Arms, Groups, and Interventions

Arm Title
ASV Arm
Arm Type
Other
Arm Description
The measures are performed during the annual consultation required by the French Social Security for the renewal of the reimbursement of the ASV care.
Intervention Type
Device
Intervention Name(s)
Adaptive Servo-Ventilation
Intervention Description
Adaptive Servo-Ventilation proceeds by continually measuring either minute ventilation or airflow and calculates a target ventilation to be applied as needed.
Primary Outcome Measure Information:
Title
Residual Apnea Hypopnea Index (AHI) evaluated by the ASV device and associated pressure settings
Description
Relationship between the residual AHI and the associated pressure settings, in function of the phenotype of the patients (presence or absence of cardiopathy, presence or absence of altered left ventricular ejection fraction (≤45% or > 45%)
Time Frame
The measures are performed during the annual consultation required by the French Social Security for the renewal of the reimbursement of the ASV care. The measures are obtained after analysis of the six latest months data of the device.
Secondary Outcome Measure Information:
Title
Sleep Disorder Breathing involved in the initial prescription of ASV
Description
The data are obtained after questioning the patient (Epworth, Pichot and satisfaction scales) or after analysis of the six latest months data of the device or after analysis of the polygraphy/oximetry (if necessary and prescribed by the doctor in order to monitoring the patient for the renewal consultation of the ASV care and reimbursement by the French Social Security).
Time Frame
The day of inclusion
Title
ASV compliance (number of hour per day, number of day with ≥3 hours in the past 6 months)
Description
The data are obtained after questioning the patient (Epworth, Pichot and satisfaction scales) or after analysis of the six latest months data of the device or after analysis of the polygraphy/oximetry (if necessary and prescribed by the doctor in order to monitoring the patient for the renewal consultation of the ASV care and reimbursement by the French Social Security).
Time Frame
The day of inclusion during the consultation or in a maximum delay of 15 days after (if the patient forgot to bring his device)
Title
Type of device used nad history of device used (CPAP used before ASV ?)
Description
The data are obtained after questioning the patient (Epworth, Pichot and satisfaction scales) or after analysis of the six latest months data of the device or after analysis of the polygraphy/oximetry (if necessary and prescribed by the doctor in order to monitoring the patient for the renewal consultation of the ASV care and reimbursement by the French Social Security)
Time Frame
The day of inclusion during the consultation or in a maximum delay of 15 days after (if the patient forgot to bring his device)
Title
Used or not of an auto-EPAP
Description
The data are obtained after questioning the patient (Epworth, Pichot and satisfaction scales) or after analysis of the six latest months data of the device or after analysis of the polygraphy/oximetry (if necessary and prescribed by the doctor in order to monitoring the patient for the renewal consultation of the ASV care and reimbursement by the French Social Security).
Time Frame
The day of inclusion during the consultation or in a maximum delay of 15 days after (if the patient forgot to bring his device)
Title
Settings of the device (Inspiratory and Expiratory pressures, duration of pressurization, backup frequency)
Description
The data are obtained after questioning the patient (Epworth, Pichot and satisfaction scales) or after analysis of the six latest months data of the device or after analysis of the polygraphy/oximetry (if necessary and prescribed by the doctor in order to monitoring the patient for the renewal consultation of the ASV care and reimbursement by the French Social Security).
Time Frame
The day of inclusion during the consultation or in a maximum delay of 15 days after (if the patient forgot to bring his device)
Title
Type of mask used and historical use of mask
Description
The data are obtained after questioning the patient (Epworth, Pichot and satisfaction scales) or after analysis of the six latest months data of the device or after analysis of the polygraphy/oximetry (if necessary and prescribed by the doctor in order to monitoring the patient for the renewal consultation of the ASV care and reimbursement by the French Social Security).
Time Frame
The day of inclusion during the consultation or in a maximum delay of 15 days after (if the patient forgot to bring his device)
Title
Changes in AHI as compared to baseline
Description
The data are obtained after questioning the patient (Epworth, Pichot and satisfaction scales) or after analysis of the six latest months data of the device or after analysis of the polygraphy/oximetry (if necessary and prescribed by the doctor in order to monitoring the patient for the renewal consultation of the ASV care and reimbursement by the French Social Security).
Time Frame
The day of inclusion during the consultation or in a maximum delay of 15 days after (if the patient forgot to bring his device)
Title
Changes in Daytime Sleepiness by measuring Epworth scale as compared to baseline if available
Description
The data are obtained after questioning the patient (Epworth, Pichot and satisfaction scales) or after analysis of the six latest months data of the device or after analysis of the polygraphy/oximetry (if necessary and prescribed by the doctor in order to monitoring the patient for the renewal consultation of the ASV care and reimbursement by the French Social Security).
Time Frame
The day of inclusion
Title
Changes in Asthenia by measuring Pichot scale as compared to baseline if available
Description
The data are obtained after questioning the patient (Epworth, Pichot and satisfaction scales) or after analysis of the six latest months data of the device or after analysis of the polygraphy/oximetry (if necessary and prescribed by the doctor in order to monitoring the patient for the renewal consultation of the ASV care and reimbursement by the French Social Security).
Time Frame
The day of inclusion
Title
Number of hospitalization during the last year and etiology of the hospitalization
Description
The data are obtained after questioning the patient (Epworth, Pichot and satisfaction scales) or after analysis of the six latest months data of the device or after analysis of the polygraphy/oximetry (if necessary and prescribed by the doctor in order to monitoring the patient for the renewal consultation of the ASV care and reimbursement by the French Social Security).
Time Frame
The day of inclusion
Title
Presence of a cardiomyopathy
Description
The data are obtained after questioning the patient (Epworth, Pichot and satisfaction scales) or after analysis of the six latest months data of the device or after analysis of the polygraphy/oximetry (if necessary and prescribed by the doctor in order to monitoring the patient for the renewal consultation of the ASV care and reimbursement by the French Social Security).
Time Frame
The day of inclusion
Title
Treatment of the cardiomyopathy (medication consumption and use of cardiac implant will be reported)
Description
The data are obtained after questioning the patient (Epworth, Pichot and satisfaction scales) or after analysis of the six latest months data of the device or after analysis of the polygraphy/oximetry (if necessary and prescribed by the doctor in order to monitoring the patient for the renewal consultation of the ASV care and reimbursement by the French Social Security).
Time Frame
The day of inclusion
Title
Number of patients not showing up for the annual consultation
Description
The data are obtained after questioning the patient (Epworth, Pichot and satisfaction scales) or after analysis of the six latest months data of the device or after analysis of the polygraphy/oximetry (if necessary and prescribed by the doctor in order to monitoring the patient for the renewal consultation of the ASV care and reimbursement by the French Social Security).
Time Frame
One year after the start of the study

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Written informed consent Age more than 18 years (inclusive) Patient treated with ASV for at least one year,and eligible for care and for the reimbursement by the French Social Security rules. Patient presenting at the annual control consultation for the continuation of the ASV treatment according to the French Social Security rules. Exclusion Criteria: Pregnancy, intention of being pregnant, breastfeeding. Inability to understand the nature and aims of the study or to communicate with the investigator Simultaneous participation in another trial with an exclusion clause to participate to an other trial. No affiliation to the French social security Loss of personal capacity resulting in state protection Deprivation of liberty by judicial or administrative decision
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Dany JAFFUEL, MD, PhD
Organizational Affiliation
Polyclinic Saint-Privat
Official's Role
Principal Investigator
Facility Information:
Facility Name
Polyclinic Saint-Privat
City
Boujan sur Libron
ZIP/Postal Code
34480
Country
France
Facility Name
CHU Dijon
City
Dijon
ZIP/Postal Code
21079
Country
France
Facility Name
Hôpital Nord
City
Marseille
ZIP/Postal Code
13015
Country
France
Facility Name
Arnaud de Villeneuve University Hospital
City
Montpellier
ZIP/Postal Code
34295
Country
France
Facility Name
Hôpital Pitié Salpetrière
City
Paris
ZIP/Postal Code
75651
Country
France

12. IPD Sharing Statement

Citations:
PubMed Identifier
31665026
Citation
Jaffuel D, Philippe C, Rabec C, Mallet JP, Georges M, Redolfi S, Palot A, Suehs CM, Nogue E, Molinari N, Bourdin A. What is the remaining status of adaptive servo-ventilation? The results of a real-life multicenter study (OTRLASV-study) : Adaptive servo-ventilation in real-life conditions. Respir Res. 2019 Oct 29;20(1):235. doi: 10.1186/s12931-019-1221-9.
Results Reference
result
PubMed Identifier
32957983
Citation
Jaffuel D, Rabec C, Philippe C, Mallet JP, Georges M, Redolfi S, Palot A, Suehs CM, Nogue E, Molinari N, Bourdin A. Patterns of adaptive servo-ventilation settings in a real-life multicenter study: pay attention to volume! : Adaptive servo-ventilation settings in real-life conditions. Respir Res. 2020 Sep 21;21(1):243. doi: 10.1186/s12931-020-01509-7.
Results Reference
result
PubMed Identifier
27155898
Citation
Jaffuel D, Mallet JP, Combes N, Palot A, Rabec C, Molinari N, Jaber S, Bourdin A. [Adaptive servo-ventilation after the SERVE-HF study: The swan song?]. Rev Mal Respir. 2016 Sep;33(7):641-4. doi: 10.1016/j.rmr.2016.04.001. Epub 2016 May 5. No abstract available. French.
Results Reference
result

Learn more about this trial

Adaptive Servo-Ventilation in "Real Life" Conditions : the OTRLASV Study

We'll reach out to this number within 24 hrs